Combivir and Breastfeeding: An Overview
Both of the components of
Combivir® (
lamivudine/zidovudine) pass through breast milk. Women with
HIV or
AIDS in developed countries (such as the United States) are typically advised not to breastfeed in order to reduce the chance of transmitting the virus to their infants. Therefore, most women taking Combivir should avoid breastfeeding.
Combivir and Breastfeeding: What Does the Research Say?
Studies have shown that both
lamivudine and
zidovudine pass through breast milk. More importantly, the HIV virus also passes through breast milk. Any HIV-infected woman who can safely feed her baby formula should not breastfeed. There are some situations in which formula feeding is not safe, such as if no clean water supply is available to mix the formula or wash the bottles. In these situations, it is difficult to know whether breastfeeding or formula feeding is more dangerous. In general, using both breastfeeding and formula feeding is considered to be the most dangerous, as
digestive system irritation or infections from unclean water can allow HIV to pass into the body from the digestive tract more easily.
Talking With Your Healthcare Provider About Combivir and Breastfeeding
You should talk with your healthcare provider about Combivir and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Combivir and breastfeeding that is right for you.